Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Acknowledgment of Support

This activity is supported by an educational grant from Bausch + Lomb.

Advances In™ Uveitic Macular Edema: The Future of Treatment for Patients With UME

Release Date: March 31, 2021
Expiration Date: March 31, 2022

Activity Overview

This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of uveitic macular edema, with a forward-looking perspective on how new and novel agents might impact clinical practice. The essentials of diagnosis, current and emerging treatment strategies, and management of treatment-related toxicities will be presented in a multimedia format, including a series of video interviews with an expert thought leader integrated into text-based elements.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Bausch + Lomb.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This educational activity is directed toward ophthalmologists and other health care professionals involved in management of patients with uveitic macular edema.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Discuss the various etiologies of uveitic macular edema
  • Evaluate clinical and imaging findings in a differential diagnosis of uveitic macular edema
  • Describe the efficacy, safety, benefits, and limitations of existing and future corticosteroid treatments in patients with uveitic macular edema

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.

Faculty

Steven Yeh, MD
Steven Yeh, MD
Stanley Truhlsen Jr. Professor of Ophthalmology
Director, Uveitis and Vitreoretinal Disease
Truhlsen Eye Institute
University of Nebraska Medical Center
Omaha, Nebraska

Disclosures: Consultant: Bausch + Lomb.

Jessica G. Shantha, MD
Jessica G. Shantha, MD
Assistant Professor
Emory Eye Center
Division of Uveitis and Medical Retina
Atlanta, Georgia

Disclosures: Grant/Research Support: NEI K23.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
    123
45678910
11121314151617
18192021222324
252627282930
Filter By